scholarly journals A tertiary centre experience comparing new temperature-controlled high-power short-duration ablation technology with standard radiofrequency and cryo-energy ablation

2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
A Mavilakandy ◽  
B Sidhu ◽  
S Man ◽  
I Antoun ◽  
Z Vali ◽  
...  

Abstract Introduction Pulmonary vein isolation (PVI) is an established treatment strategy for atrial fibrillation (AF). Radiofrequency (RF) ablation technology has evolved over the last decade with the very high-power short-duration (vHPSD) temperature-controlled ablation approach emerging as the latest development. The aim of this study was to determine the procedural efficacy, metrics and safety of vHPSD ablation with conventional power-controlled RF (PCRF) ablation and cryo-energy ablation (CRYO). Methods A prospective single tertiary centre analysis was performed on patients undergoing first time PVI ablation from 2019 to 2020. The population was divided in to 4 treatment arms; vHPSD, high-power short-duration (HPSD), PCRF and CRYO. Demographics, clinical and procedural metrics such as PVI duration, ablation time and sedation requirement were collated. Patients were monitored for perioperative complications. Results One hundred patients underwent ablation with 25 cases conducted in each arm. Complete PVI was attained in all study subjects. For the vHPSD group, PVI procedural duration, ablation and fluoroscopy times were 71.7±6.35 min, 9.21±0.76 min and 15.1±1.50 min respectively. The HSPD group exhibited total PVI, burn and fluoroscopy times of 90.2±5.59 min (p=0.03), 10.3±2.40 min (p<0.0001) and 34.1±1.67 min (p=0.1) respectively. In comparison, the PCRF group exhibited longer procedure duration, ablation and fluoroscopy times of 93.3±6.50 min (p=0.01), 15.2±1.73 min (p<0.0001), 37.8±2.47 min (p=0.870). Whereas procedural and fluoroscopy times of 96.3±7.1 min (p=0.01) and 18.8±1.31 (p=0.05) were observed in the cryo-ablation group. Procedural doses of morphine and midazolam for the vHPSD, HPSD, PCRF and CRYO group were 11.3 mg + 4.00 mg, 15.5 mg (p=0.0003) + 9.33 mg (p=0.0003), 15.7 mg (p=0.0002) + 8.03 mg (p=0.02), and 8.19 mg (p=0.01) + 4.84 mg (p=0.303) respectively. No adverse procedural events were recorded for the vHPSD while 2 pericardial effusions occurred in the PCRF group, 1 cardiac tamponade in the HPSD group and 2 transient ischaemic attacks in the CRYO group. Conclusion With the emergence of vHPSD RF ablation, preliminary findings indicate significant potential in reduction of procedural and ablation time. Further analysis is ongoing in order to ascertain longer-term efficacy and patient safety. FUNDunding Acknowledgement Type of funding sources: None. Intraprocedural outcomes Intraprocedural outcomes

EP Europace ◽  
2021 ◽  
Vol 23 (Supplement_3) ◽  
Author(s):  
CH Heeger ◽  
MS Sano ◽  
RMS Meyer-Saraei ◽  
CE Eitel ◽  
HL Phan ◽  
...  

Abstract Funding Acknowledgements Type of funding sources: None. Background Catheter ablation for atrial fibrillation (AF) treatment provides effective and durable PVI associated with encouraging clinical outcome. The novel QDot ablation catheter with Qmode + ablation mode (90W/4sec, Figure 1) offers the ability to possibly improve safety and decrease ablation procedure times. Aims We aim to evaluate safety and efficacy of the very high-power short-duration (vHP-SD) temperature-controlled radiofrequency (RF) ablation Qmode + mode for pulmonary vein isolation (PVI) utilizing the novel QDot micro ablation catheter. The data was compared to conventional power-controlled ablation index (AI) guided PVI. Methods Twenty-five consecutive patients with paroxysmal or persistent AF were prospectively enrolled, underwent vHP-SD based PVI (vHP-SD group) and were compared to 25 consecutive patients treated with conventional CF-sensing catheters (control). Results All PVs were successfully isolated utilizing Qmode +. The total median RF ablation time was vHP-SD: 334 (282, 369) sec. vs control: 1567 (1250, 1756) sec. (p < 0.0001), the median procedure time was vHP-SD: 56 (48-62) vs. control: 104 (92-122) min (p < 0.0001). No differences in periprocedural complications were observed. Conclusions The novel Qmode + provides safe and effective PVI with impressive short RF time and short procedures times. Procedure time and RF time were substantial lower in the vHP-SD group. Abstract Figure 1


Author(s):  
Roland Tilz ◽  
Makoto Sano ◽  
Julia Vogler ◽  
Thomas Fink ◽  
Roza Meyer-Saraei ◽  
...  

Background: Catheter ablation for atrial fibrillation (AF) treatment provides effective and durable pulmonary vein isolation (PVI) and is associated with encouraging clinical outcome. A novel CF sensing temperature-controlled radiofrequency (RF) ablation catheter allows for very high-power short-duration (vHP-SD, 90W/4 seconds) ablation aiming a potentially safer, more effective and faster ablation. We thought to evaluate preliminary safety and efficacy of vHP-SD ablation for PVI utilizing a novel vHP-SD catheter. The data was compared to conventional power-controlled ablation index (AI) guided PVI utilizing conventional contact force (CF) sensing catheters. Methods and Results: Fifty-six patients with paroxysmal or persistent AF were prospectively enrolled in this study. Twenty-eight consecutive patients underwent vHP-SD based PVI (vHP-SD group) and were compared to 28 consecutive patients treated with conventional CF-sensing catheters utilizing the AI (control group). All PVs were successfully isolated using vHP-SD. The median RF ablation time for vHP-SD was 338 (IQR 286, 367) seconds vs control 1580 (IQR 1350, 1848) seconds (p<0.0001), the median procedure duration was vHP-SD 55 (IQR 48-60) minutes vs. control 105 (IQR 92-120) minutes (p<0.0001). No differences in periprocedural complications were observed. Conclusions: This preliminary data of the novel vHP-SD ablation mode provides safe and effective PVI. Procedure duration and RF ablation time were substantially shorter in the vHP-SD group in comparison to the control group.


2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
E Kulstad ◽  
M Mercado-Montoya ◽  
S Shah

Abstract Introduction Recent clinical data show that high-power, short-duration (HPSD) radiofrequency (RF) ablation can result in a similar esophageal injury rate as traditional low-power, long-duration (LPLD) ablation. Existing methods to prevent esophageal injury have yielded mixed results and can result in prolonged procedure time, potentially increasing the incidence of post-operative cognitive dysfunction. A new esophageal cooling device currently available for whole-body temperature modulation is being studied for the prevention of esophageal injury during LPLD RF ablation and cryoablation. We sought to develop a mathematical model of HPSD ablation in order to quantify the capability of this new esophageal cooling device to protect from esophageal injury under high-power conditions. Methods Using a model we developed of HPSD RF ablation in the left atrium, we measured the change in esophageal lesion formation and the depth of lesions (measured as percent transmurality) with the esophageal cooling device in place and operating at a temperature from 5°C to 37°C. Tissue parameters, including thermal conductivity, were set to average values obtained from existing literature, and energy settings were evaluated at 50W for between 5 and 10 seconds, and at 90W for a duration of 4 seconds. Results Esophageal injury as measured by percent transmurality was considerably higher at 50W and 10s duration than at 90W of power with 4s duration, although both settings showed potential for esophageal injury. The protective effect of the esophageal cooling device was evident for both cases, with a greater effect when using 50W for 10s (Figure 1). At the coldest device settings, using a 5 min pre-cooling period also reduced the transmurality of the intended atrial lesions. Esophageal protection in HPSD ablation Conclusions Esophageal cooling with a new patient temperature management device shows protective effects against thermal injury during RF ablation across a range of tissue thermal conductivity, using a variety of high-power settings, including 90W applied for 4 seconds. Adjusting the cooling power by adjusting the circulating water temperature in the device allows for a tailoring of the protective effects to operating conditions. Acknowledgement/Funding Attune Medical


2019 ◽  
Vol 5 (7) ◽  
pp. 778-786 ◽  
Author(s):  
Vivek Y. Reddy ◽  
Massimo Grimaldi ◽  
Tom De Potter ◽  
Johan M. Vijgen ◽  
Alan Bulava ◽  
...  

2021 ◽  
Author(s):  
Kaihao Gu ◽  
Shengjie Yan ◽  
Xiaomei Wu

Abstract Background: High power-short duration ablation is an emerging conception for cardiac RF treatment. But the biophysical ablation properties of this technique have not been fully explored. This study compared the electric field characteristics and thermal lesion dimension in High power-short duration (HP-SD) radio frequency (RF) ablation and standard RF ablation by using the finite element method. Results: The results demonstrated that the lesion size and temperature in HP–SD RF ablation increased faster than standard RF ablation. The thermal lesion volume in both ablation modes demonstrated a linear increase and the rate of increase of HP–SD RF ablation grew faster than that of standard RF ablation. For HP–SD application at 50 W for 5 s, the lesion depth was shallower (1.74 to 2.1 mm vs 2.40 to 3.15 mm) and the surface lesion diameter was broader (2.76 to 3.32 mm vs 2.42 to 2.66 mm) than that for standard RF ablation at 25 W for 30 s. Conclusion: Compared with standard RF ablation, HP–SD RF ablation creates a broader lesion width and surface lesion diameter but shallower lesion depth, with a faster increase in temperature. HP–SD ablation is more able to achieve uniform and contiguous lesion shape, which is a suitable for point-to-point RF ablation procedures.Higher temperature was formed in deeper space of cardiac tissue in HP–SD ablation. The duration of HP–SD ablation should be strictly controlled for preventing the steam occur in tissue.


2020 ◽  
Vol 31 (6) ◽  
pp. 1332-1339 ◽  
Author(s):  
Felix Bourier ◽  
Konstantinos Vlachos ◽  
Antonio Frontera ◽  
Claire A. Martin ◽  
Anna Lam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document